Trial intelligence / Profile preview

GW274150 PK and Safety in Adult and Elderly RA

NCT00370435Phase 2Completed

Sponsor
GSK
Start
Aug 2005
Primary completion
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of GW274150 in rheumatoid arthritis (RA), sponsored by GSK. Started Aug 2005; status: completed.

02

Drugs

GW274150
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00370435.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00370435.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call